UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the Fiscal Year Ended December 31, 2019 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from _____ to _____ Commission File No. 001-38445 HELIUS MEDICAL TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 36-4787690 (State or other juris ...

Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q3 2019 Earnings Conference Call November 12, 2019 8:00 AM ET Company Participants Phil Deschamps - Chief Executive Officer Joyce LaViscount - Chief Financial Officer & Chief Operating Officer Ryan Scott - Clinic Director at Advantage 4 Athletes Conference Call Participants Steven Lichtman - Oppenheimer & Company Jeff Porter - Porter Capital Anthony Lamport - Lambda Fund Operator Good morning, ladies and gentlemen, and welcome to the Third Quarter of Fiscal Ye ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period to Commission File No. 001-38445 HELIUS MEDICAL TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer ...

Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q2 2019 Earnings Conference Call August 8, 2019 4:30 PM ET Company Participants Phil Deschamps – Chief Executive Officer Marcos Rodrigues – Physical Therapist-Neurotherapy Montreal Clinic Joyce LaViscount – Chief Financial Officer and Chief Operating Officer Conference Call Participants Ameer Burshaw – Oppenheimer Jeff Porter – Porter Capital Sebastian van Berkom – Van Berkom and Associates Operator Good afternoon, ladies and gentlemen, and welcome to the Seco ...

For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period to Commission File No. 001-38445 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange ...

Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Phil Deschamps - CEO Joyce LaViscount - CFO & COO Conference Call Participants Marie Thibault - BTIG Operator Good afternoon, ladies and gentlemen, and welcome to the First Quarter of Fiscal Year 2019 Earnings Conference Call for Helius Medical Technologies. [Operator Instructions] Please note that this conference is being recorded, and that the recording will be available on the comp ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period to UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Commission File No. 001-38445 HELIUS MEDICAL TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) Delaware 36-4787690 (State or other jurisdiction of ...

Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q4 2018 Earnings Conference Call March 14, 2019 4:30 PM ET Company Participants Phil Deschamps - CEO Joyce LaViscount - CFO and COO Conference Call Participants Steven Lichtman - Oppenheimer Sean Lavin - the BTIG Operator Good afternoon ladies, and gentlemen and welcome to the Fourth Quarter of Fiscal Year 2018 Earnings Conference Call for Helius Medical Technologies. At this time, all participants have been placed in a listen-only mode. Please note that this ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the Fiscal Year Ended December 31, 2018 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from _____ to _____ Commission File No. 001-38445 HELIUS MEDICAL TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 36-4787690 (State or other juris ...